Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
about
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectivesSingle vs. combination immunotherapeutic strategies for glioma.Advances in neuro-oncology imaging.Isocitrate dehydrogenase mutations in gliomasImmunotherapy in glioblastoma: emerging options in precision medicinePrioritization schema for immunotherapy clinical trials in glioblastoma.IGFBP2 expression predicts IDH-mutant glioma patient survival.Glioblastoma targeted therapy: updated approaches from recent biological insights.The Effect of Molecular Diagnostics on the Treatment of Glioma.IDH mutations in cancer and progress toward development of targeted therapeutics.Vaccine-based immunotherapeutic approaches to gliomas and beyond.Further understanding of the pathology of glioma: implications for the clinic.Concepts in glioma immunotherapy.New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.Current therapeutic approaches to diffuse grade II and III gliomas.Biological Role and Therapeutic Potential of IDH Mutations in Cancer.IDH1 is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environmentBridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas
P2860
Q28066926-9980D79B-B25E-4B2D-A11A-729771B86DA1Q33746041-7026DAAE-C8DD-468C-8E9E-A266407E98D0Q36339461-9FFF1AE8-F064-441B-B287-77DBC209A389Q36367409-26E81325-FD88-4CB2-8534-E5BD951CFE48Q37050960-CF4D975A-B02E-4F29-987D-B02F3DFBF775Q37078999-07DBA84C-C960-4B50-B0BA-F0DEFA06B075Q37702193-B1915F8D-E0D0-4B04-87AC-EBD27EAA9342Q38597700-DA0C7006-6970-4CCB-A9A1-C90B6A5C3E79Q38743781-B9B5F025-317F-4E49-9952-47F22169F040Q38785528-A5DAEFDC-6D23-40B6-80AB-E6A3BB51EF22Q38789860-7E83485B-50DC-47E5-9D94-03C13AE25950Q38844945-C7E12F03-95C5-47F8-B61C-9AC9B96F1F50Q38909071-6287C15B-AC53-46F5-AC07-339D64CB9A01Q39167472-D4739A75-2830-4256-9725-C1BB309102F8Q39383501-0335014A-272B-4027-80B1-DD5CA988488AQ41146626-D137DE9C-AA8B-4187-9DB0-5170A3F658FCQ41654263-FF0E539D-7AC4-4175-985F-42865B96DE37Q47605895-51F5EADD-674E-469B-A62C-54BF218684E1Q49317056-B9209116-0140-4040-BE40-02903C50C6A9Q55456962-0A793679-5E33-42CE-8D81-E42EB8EAC36CQ58738690-B79843DE-73E0-4E4D-A32A-878AAAA256EEQ58766030-B68C850E-CAB6-4F29-8E7C-E44396C7BDAA
P2860
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Effective immuno-targeting of ...... model of intracranial glioma.
@en
type
label
Effective immuno-targeting of ...... model of intracranial glioma.
@en
prefLabel
Effective immuno-targeting of ...... model of intracranial glioma.
@en
P2093
P2860
P50
P1476
Effective immuno-targeting of ...... model of intracranial glioma.
@en
P2093
Antonella Isacchi
Bianca Pollo
Federico Riccardi Sirtori
Gianpaolo Fogliatto
Ileana Zucca
Lorella Valletta
Maria Grazia Bruzzone
P2860
P2888
P356
10.1186/S40478-014-0180-0
P577
2015-01-21T00:00:00Z
P5875
P6179
1037640252